BBLG - Bone Biologics Corporation

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 2.76M
Enterprise value 15.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.99
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.94

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 3-88.28%
S&P500 52-week change 32.74%
52-week high 31.9700
52-week low 30.1400
50-day moving average 30.2209
200-day moving average 30.4705

Share statistics

Avg vol (3-month) 3567.49k
Avg vol (10-day) 31.32M
Shares outstanding 516.7M
Implied shares outstanding 6N/A
Float 810.1M
% held by insiders 140.14%
% held by institutions 118.31%
Shares short (14 May 2023) 4347.6k
Short ratio (14 May 2023) 41.27
Short % of float (14 May 2023) 44.52%
Short % of shares outstanding (14 May 2023) 42.08%
Shares short (prior month 13 Apr 2023) 4103.68k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 323 Jul 2018
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-59.44%
Return on equity (ttm)-102.26%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
Net income avi to common (ttm)-4.51M
Diluted EPS (ttm)-0.3300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.19M
Total cash per share (mrq)0.37
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)1.69
Book value per share (mrq)0.17

Cash flow statement

Operating cash flow (ttm)-4.06M
Levered free cash flow (ttm)-485.64k